| Identification | Back Directory | [Name]
Anhydro Abiraterone | [CAS]
154229-20-6 | [Synonyms]
Anhydro Abiraterone
Abiraterone Acetate IMP
Abiraterone Anhydro Impurity
Abiraterone ImpurityABCDEFGHI
3-((8R,9S,10R,13S,14S)-10,13-dimethyl
17-(Pyridin-3-yl)androsta-3,5,16-triene
Pyridine, 3-androsta-3,5,16-trien-17-yl-
Abiraterone acetate impurity 1 (abiraterone)
Anhydro Abiraterone/17-(Pyridin-3-yl)androsta-3,5,16-triene
3-((8R,9S,10R,13S,14S)-10,13-dimethyl-2,7,8,9,10,11,12,13,14,15- decahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine | [Molecular Formula]
C24H29N | [MDL Number]
MFCD00924101 | [MOL File]
154229-20-6.mol | [Molecular Weight]
331.49 |
| Chemical Properties | Back Directory | [Melting point ]
118 - 122°C | [Boiling point ]
475.0±45.0 °C(Predicted) | [density ]
1.10±0.1 g/cm3(Predicted) | [storage temp. ]
-20°C Freezer | [solubility ]
Chloroform (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
5.31±0.12(Predicted) | [color ]
Off-White to Pale Beige | [Major Application]
pharmaceutical small molecule |
| Safety Data | Back Directory | [WGK Germany ]
WGK 3 | [Storage Class]
11 - Combustible Solids | [Hazard Classifications]
Aquatic Chronic 1
Repr. 2
STOT RE 2 |
| Hazard Information | Back Directory | [Uses]
Anhydro Abiraterone is an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer. |
|
| Company Name: |
Energy Chemical
|
| Telephone: |
400-0056266 |
| Website: |
www.energy-chemical.com |
| Company Name: |
Roark Standards
|
| Telephone: |
0755-83552066 15986688328 |
| Website: |
roarkstandards.com |
| Company Name: |
TOSUN PHARM
|
| Telephone: |
020-66392521-118 18922260391 |
| Website: |
www.toref.cn/ |
|